Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04502706 |
Title | Study of FSI-189 as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin Lymphoma |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Gilead Sciences |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Alabama Comprehensive Cancer Center | Birmingham | Alabama | 35233 | United States | Details | |
City of Hope | Duarte | California | 91010 | United States | Details | |
Florida Cancer Specialists | Sarasota | Florida | 34232 | United States | Details | |
Washington University School of Medicine | Saint Louis | Missouri | 63110 | United States | Details | |
University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | United States | Details |